{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:43:12Z","timestamp":1792028592464,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Improving quality of life (QoL) is important for the treatment of people with bipolar disorder (BD). Early-BipoLife is a German multicentre naturalistic, prospective-longitudinal observational cohort study investigating early recognition and intervention in people at increased risk of developing a BD. This analysis aims to investigate influencing factors and changes in QoL as a basis for the development of early intervention strategies in patients with at risk syndrome for BD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>A cohort of 1086 participants (15\u201335\u00a0years) with at least one risk factor (EPI<jats:italic>bipolar criteria<\/jats:italic>) for BD was assessed over the course of 2\u00a0years. Changes in QoL (WHOQOL-BREF) were evaluated in a mixed model for repeated measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to an age-matched comparison group, people at risk for BD showed significant lower QoL in all domains at baseline. The overall QoL of the psychological well-being domain of the WHOQOL-BREF increased over the 2\u00a0year study course (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The bipolar risk group (EPI<jats:italic>bipolar<\/jats:italic>) change from baseline divided into (a) decreasing, (b) increasing and (c) constant risk group in the course of 2\u00a0years. Baseline risk group assignment was not a significant predictor of change in QoL over 2\u00a0years for any of the QoL domains, but participants with an increase in risk over the 2-year course had a significantly smaller gain in QoL than the group with constant risk (<jats:italic>p<\/jats:italic>\u2009=\u20090.014) or decreasing risk (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Higher levels of QoL were associated with a higher self-rated ability to use coping strategies. Moreover, a higher level of functioning (GAF) at baseline was positively correlated with improvement of different QoL domains after 2\u00a0years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Patients with a risk syndrome for BD reported significantly reduced QoL compared to their age-matched comparison group. Risk status monitoring might be beneficial to identify individuals who could profit from an intervention to increase their QoL. Further studies promoting the development of coping strategies for successful self-management could be helpful to improve overall mental health and positively influence QoL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40345-025-00373-y","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:36:39Z","timestamp":1739867799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife)"],"prefix":"10.1186","volume":"13","author":[{"given":"Johanna","family":"Glaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Karow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Sowada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra","family":"Br\u00f6ckel-Bundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Juckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Fallgatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bechdolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Matura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kittel-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Falkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7646-6358","authenticated-orcid":false,"given":"Anja Christine","family":"Rohenkohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"1","key":"373_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00127-005-0997-8","volume":"41","author":"M Aigner","year":"2006","unstructured":"Aigner M, F\u00f6rster-Streffleur S, Prause W, Freidl M, Weiss M, Bach M. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psychiatr Epidemiol. 2006;41(1):81\u20136.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"373_CR2","unstructured":"Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF: Handbuch f\u00fcr die deutschsprachige Version der WHO Instrumente zur Erfassung von Lebensqualit\u00e4t. G\u00f6ttingen: Hofgrefe; 2000."},{"issue":"2","key":"373_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1176\/appi.ajp.157.2.213","volume":"157","author":"GA Carlson","year":"2000","unstructured":"Carlson GA, Bromet EJ, Sievers S. Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. Am J Psychiatry. 2000;157(2):213\u20139.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"373_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40501-018-0138-0","volume":"5","author":"S Conroy","year":"2018","unstructured":"Conroy S, Francis M, Hulvershorn LA. Identifying and treating the prodromal phases of bipolar disorder and schizophrenia. Curr Treat Options Psychiatry. 2018;5(1):113\u201328.","journal-title":"Curr Treat Options Psychiatry"},{"key":"373_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f510","volume":"346","author":"P Draper","year":"2013","unstructured":"Draper P. Self or partnership management of bipolar disorder. BMJ. 2013;346: f510.","journal-title":"BMJ"},{"issue":"5","key":"373_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4088\/JCP.13r08900","volume":"76","author":"GL Faedda","year":"2015","unstructured":"Faedda GL, Marangoni C, Serra G, Salvatore P, Sani G, V\u00e1zquez GH, et al. Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry. 2015;76(5):614\u201324.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"373_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/bdi.12831","volume":"21","author":"GL Faedda","year":"2019","unstructured":"Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, et al. An International Society of Bipolar Disorders task force report: precursors and prodromes of bipolar disorder. Bipolar Disord. 2019;21(8):720\u201340.","journal-title":"Bipolar Disord"},{"key":"373_CR8","unstructured":"Fydrich T, Renneberg B, Schmitz B, Wittchen H-U. SKID II. Strukturiertes Klinisches Interview f\u00fcr DSM-IV, Achse II: Pers\u00f6nlichkeitsst\u00f6rungen. Interviewheft. Eine deutschspeachige, erw. Bearb. d. amerikanischen Originalversion d. SKID-II von: M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams, L. Benjamin, (Version 3\/96). G\u00f6ttingen: Hogrefe; 1997. 36 p."},{"issue":"1","key":"373_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11205-005-5552-1","volume":"77","author":"G Hawthorne","year":"2006","unstructured":"Hawthorne G, Herrman H, Murphy B. Interpreting the WHOQOL-br\u00e8f: preliminary population norms and effect sizes. Soc Indic Res. 2006;77(1):37\u201359.","journal-title":"Soc Indic Res"},{"issue":"9","key":"373_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00787-022-02058-8","volume":"31","author":"N Hertz-Palmor","year":"2022","unstructured":"Hertz-Palmor N, Gothelf D. The importance of measuring quality of life as a treatment outcome in child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2022;31(9):1331\u20135.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"373_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11920-011-0229-8","volume":"13","author":"OD Howes","year":"2011","unstructured":"Howes OD, Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Curr Psychiatry Rep. 2011;13(6):493\u20139.","journal-title":"Curr Psychiatry Rep"},{"key":"373_CR34","unstructured":"IBM. SPSS. Version 27 ed2020."},{"issue":"6","key":"373_CR12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/schbul\/sbs068","volume":"38","author":"HK Ising","year":"2012","unstructured":"Ising HK, Veling W, Loewy RL, Rietveld MW, Rietdijk J, Dragt S, et al. The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population. Schizophr Bull. 2012;38(6):1288\u201396.","journal-title":"Schizophr Bull"},{"key":"373_CR13","unstructured":"Jack M. Entwicklung eines ressourcen- und selbstmanagementorientierten Evaluationsinstrumentes zur psychotherapeutischen Informationsgewinnung und Qualit\u00e4tssicherung in der station\u00e4ren Psychosomatik. Regensburg: Roderer; 2001."},{"issue":"9","key":"373_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11920-014-0485-5","volume":"16","author":"CA Janney","year":"2014","unstructured":"Janney CA, Bauer MS, Kilbourne AM. Self-management and bipolar disorder\u2013a clinician\u2019s guide to the literature 2011\u20132014. Curr Psychiatry Rep. 2014;16(9):485.","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"373_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3109\/09638237.2011.600786","volume":"20","author":"S Jones","year":"2011","unstructured":"Jones S, Deville M, Mayes D, Lobban F. Self-management in bipolar disorder: the story so far. J Ment Health. 2011;20(6):583\u201392.","journal-title":"J Ment Health"},{"issue":"1\u20133","key":"373_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jad.2012.10.003","volume":"147","author":"S Jones","year":"2013","unstructured":"Jones S, Mulligan LD, Higginson S, Dunn G, Morrison AP. The bipolar recovery questionnaire: psychometric properties of a quantitative measure of recovery experiences in bipolar disorder. J Affect Disord. 2013;147(1\u20133):34\u201343.","journal-title":"J Affect Disord"},{"issue":"1","key":"373_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/mental.3708","volume":"1","author":"E Karasouli","year":"2014","unstructured":"Karasouli E, Adams A. Assessing the Evidence for e-resources for mental health self-management: a systematic literature review. JMIR Ment Health. 2014;1(1): e3.","journal-title":"JMIR Ment Health"},{"key":"373_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jad.2016.08.075","volume":"207","author":"D Lee","year":"2017","unstructured":"Lee D, Cha B, Park CS, Kim BJ, Lee CS, Lee SJ, et al. Effects of resilience on quality of life in patients with bipolar disorder. J Affect Disord. 2017;207:434\u201341.","journal-title":"J Affect Disord"},{"issue":"3","key":"373_CR19","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jad.2011.06.043","volume":"136","author":"K Leopold","year":"2012","unstructured":"Leopold K, Ritter P, Correll CU, Marx C, \u00d6zg\u00fcrdal S, Juckel G, et al. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J Affect Disord. 2012;136(3):1000\u201310.","journal-title":"J Affect Disord"},{"key":"373_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.euroneuro.2023.10.001","volume":"78","author":"J Martini","year":"2023","unstructured":"Martini J, Br\u00f6ckel KL, Leopold K, Berndt C, Sauer C, Maicher B, et al. Young people at risk for developing bipolar disorder: two-year findings from the multicenter prospective, naturalistic Early-BipoLife study. Eur Neuropsychopharmacol. 2023;78:43\u201353.","journal-title":"Eur Neuropsychopharmacol"},{"key":"373_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1477-7525-3-72","volume":"3","author":"EE Michalak","year":"2005","unstructured":"Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes. 2005;3:72.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"373_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","volume":"29","author":"TJ Miller","year":"2003","unstructured":"Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703\u201315.","journal-title":"Schizophr Bull"},{"key":"373_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jad.2017.01.026","volume":"212","author":"E Morton","year":"2017","unstructured":"Morton E, Michalak EE, Murray G. What does quality of life refer to in bipolar disorders research? A systematic review of the construct\u2019s definition, usage and measurement. J Affect Disord. 2017;212:128\u201337.","journal-title":"J Affect Disord"},{"issue":"7","key":"373_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1017\/S0033291717002495","volume":"48","author":"E Morton","year":"2018","unstructured":"Morton E, Murray G, Michalak EE, Lam RW, Beaulieu S, Sharma V, et al. Quality of life in bipolar disorder: towards a dynamic understanding. Psychol Med. 2018;48(7):1111\u20138.","journal-title":"Psychol Med"},{"issue":"8","key":"373_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/bdi.12016","volume":"14","author":"G Murray","year":"2012","unstructured":"Murray G, Michalak EE. The quality of life construct in bipolar disorder research and practice: past, present, and possible futures. Bipolar Disord. 2012;14(8):793\u20136.","journal-title":"Bipolar Disord"},{"key":"373_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cpr.2017.01.002","volume":"52","author":"G Murray","year":"2017","unstructured":"Murray G, Leitan ND, Thomas N, Michalak EE, Johnson SL, Jones S, et al. Towards recovery-oriented psychosocial interventions for bipolar disorder: quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms. Clin Psychol Rev. 2017;52:148\u201363.","journal-title":"Clin Psychol Rev"},{"issue":"6","key":"373_CR27","first-page":"92","volume":"110","author":"A Pfennig","year":"2013","unstructured":"Pfennig A, Bschor T, Falkai P, Bauer M. The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline. Dtsch Arztebl Int. 2013;110(6):92\u2013100.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"373_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40345-020-00183-4","volume":"8","author":"A Pfennig","year":"2020","unstructured":"Pfennig A, Leopold K, Martini J, Boehme A, Lambert M, Stamm T, et al. Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife). Int J Bipolar Disord. 2020;8(1):22.","journal-title":"Int J Bipolar Disord"},{"issue":"1","key":"373_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40345-016-0066-0","volume":"4","author":"PS Ritter","year":"2016","unstructured":"Ritter PS, Bermpohl F, Gruber O, Hautzinger M, Jansen A, Juckel G, et al. Aims and structure of the German Research Consortium BipoLife for the study of bipolar disorder. Int J Bipolar Disord. 2016;4(1):26.","journal-title":"Int J Bipolar Disord"},{"issue":"4","key":"373_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2174\/138161212799316064","volume":"18","author":"F Schultze-Lutter","year":"2012","unstructured":"Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterk\u00f6tter J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm des. 2012;18(4):351\u20137.","journal-title":"Curr Pharm des"},{"issue":"1","key":"373_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of\u00a0192 epidemiological studies. Mol Psychiatry. 2022;27(1):281\u201395.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"373_CR32","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1038\/s41380-023-02298-3","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Cortese S, Vita G, De Prisco M, Radua J, Dragioti E, et al. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders. Mol Psychiatry. 2023;28(9):3671\u201387.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"373_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1023\/A:1008979825704","volume":"9","author":"J Tsevat","year":"2000","unstructured":"Tsevat J, Keck PE, Hornung RW, McElroy SL. Health values of patients with bipolar disorder. Qual Life Res. 2000;9(5):579\u201386.","journal-title":"Qual Life Res"},{"issue":"10","key":"373_CR35","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","volume":"41","author":"WHO","year":"1995","unstructured":"WHO. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403\u20139.","journal-title":"Soc Sci Med"},{"key":"373_CR36","doi-asserted-by":"crossref","unstructured":"WHOQOL-Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551\u20138.","DOI":"10.1017\/S0033291798006667"},{"key":"373_CR37","unstructured":"Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M. SKID I. Strukturiertes Klinisches Interview f\u00fcr DSM-IV. Achse I: Psychische St\u00f6rungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearb. d. amerikanischen Originalversion des SKID I. G\u00f6ttingen: Hogrefe; 1997. 122 p."}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-025-00373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40345-025-00373-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-025-00373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:36:45Z","timestamp":1739867805000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-025-00373-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1186\/s40345-025-00373-y","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Trial registration: Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders (BipoLife-A1), NCT02456545, Registered at 11 May 2015, .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PFP is supported by #NEXTGENERATIONEU (NGEU), funded by the Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006) \u2013 A Multiscale integrated approach to the study of the nervous system in health and disease (DN. 1553 11.10.2022). CB, MB, AP and PFP have received funding from the German Research Foundation (DFG) grant number GRK2773\/1 \u2013 454245598. MB has additionally received funding from Bundesministerium f\u00fcr Bildung und Forschung, and the European Commission. He served as a consultant to GH Research, Janssen-Cilag, neuraxpharm, Novartis, Shire International, Sunovion, and Takeda, and received fees from Aristo, Hexal, Janssen Cilag, and Sunovion. AR serves on advisory boards and receives speaker\u2019s honoraria from Medice, Shire\/ Takeda, Janssen, neuraxpharm, Servier and SAGE. SKS has received speaker\u2019s honoraria from Taked, Medice and Janssen in the past 3\u00a0years. CU Correll has been a consultant and\/or advisor to or has received honoraria from: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Boehringer-Ingelheim, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, J. Martini et al. European Neuropsychopharmacology 78 (2024) 43\u201353 52 MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Seqirus, SK Life Science, Sunovion, Sun Pharma, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Mindpax, LB Pharma and Quantic. All other authors state to have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}